Medical treatment of recurrent temporomandibular joint dislocation using botulinum toxin A

British Dental Journal

Volumn 183, Issue 11-12, 1997, Pages 415-417

  Moore, A P ^a   Wood, G D ^b  

^a WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b ARROWE PARK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; BOTULINUM TOXIN A; MUSCLE RELAXANT AGENT;

AGED; AMBULATORY CARE; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; CHEMOPROPHYLAXIS; DISLOCATION; DRUG ANTAGONISM; DRUG CONTRAINDICATION; DYSTONIA; ELECTROMYOGRAPHY; FEMALE; FOLLOW UP; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; JOINT INSTABILITY; LIGAMENT; MASTICATORY MUSCLE; MUSCLE WEAKNESS; PATHOPHYSIOLOGY; RECURRENT DISEASE; SCLEROTHERAPY; TEMPORAL BONE; TEMPOROMANDIBULAR JOINT DISORDER;

ACETYLCHOLINE; AGED; AMBULATORY CARE; BOTULINUM TOXIN TYPE A; CHEMOPREVENTION; DISLOCATIONS; DYSTONIA; ELECTROMYOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRAMUSCULAR; JOINT INSTABILITY; LIGAMENTS, ARTICULAR; MUSCLE WEAKNESS; NEUROMUSCULAR AGENTS; PTERYGOID MUSCLES; RECURRENCE; SCLEROTHERAPY; TEMPORAL BONE; TEMPOROMANDIBULAR JOINT DISORDERS;

EID: 0031566756     PISSN: 00070610     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bdj.4809523     Document Type: Article

References (13)

1. Undt G, Weichselbraun A, Wagner A, Kermer C, Roosse M. Recurrent mandibular dislocation under neuroleptic drug therapy treated by bilateral eminectomy. J Craniomaxillofac Surg 1996; 20: 217-218.
2. Raman U, Samray T. Unusual dislocation of the temporomandibular joints. A case report. Int J Oral Maxillofac Surg 1991; 20: 217-218.
3. Worsaae N, Thorn J J. Surgical versus nonsurgical treatment of unilateral dislocated low subcondylar fractures: a clinical study of 52 cases. J Oral Maxillofac Surg 1994; 52: 353-360.
4. Cronin A J, Llewelyn J, Hopkins R. Complications of use of carbon fibre in the temporomandibular joint: a case report. Br J Oral Maxillofac Surg 1992; 30: 186-189.
5. Zu Y D. Clinical application of sclerosing agent in treating habitual dislocation of temporomandibular joint. Chung Hua Kou Chiang Hsueh Tsa Chih 1992; 27: 148-150, 189-190.
6. To E W. A complication of the Dautry procedure. Br J Oral Maxillofac Surg 1991; 29: 100-101.
7. Srivastrva D, Rajadrya M, Chaudrey M K, Savistrava J L. The Dautrey procedure in recurrent dislocation: review of 12 cases. Int J Oral Maxillofac Surg 1994; 23: 229-231.
8. Marsden C D, Quinn N P. The dystonias. Br Med J 1990; 300: 139-144.
9. Hambleton P, Moore A P. Botulinum neurotoxins: origin, structure, molecular actions and antibodies. In Moore A P (ed). Handbook of botulinum toxin treatment. 1st ed. pp 16-27. Oxford: Blackwell Scientific, 1995.
10. Brin M F, Blitzer A, Herman S, Stewart C. Orofaciomandibular and lingual dystonia. In Moore A P (ed). Handbook of botulinum toxin treatment. 1st ed. Oxford: Blackwell Scientific, 1995.
11. Moore A P. General and clinical aspects. In Moore A P (ed). Handbook of botulinum toxin treatment. 1st ed. pp 28-53. Oxford: Blackwell Scientific, 1995.
12. Shaari C M, Sanders I. Quantifying how location and dose of botulinum toxin injections affect muscle paralysis. Muscle Nerve 1993; 16: 964-969.
13. Juniper R P. Temporomandibular joint dysfunction: a theory based upon electromyographic studies of the lateral pterygoid muscle. Br J Oral Maxillofac Surg 1984; 22: 1-8.